GO:0018910 benzene metabolic process: Xenobiotic Biotransformation Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0018910 benzene metabolic process describes the chemical reactions and pathways involving benzene (C6H6), a volatile, flammable liquid derived from coal naphtha.
In mammals, benzene metabolism is a hepatic CYP450-driven bioactivation process that produces reactive metabolites such as phenol, catechol, hydroquinone, and muconaldehyde, which are linked to hematotoxicity and leukemia [5,7].
In anaerobic environments, benzene can be degraded by microorganisms through reductive and hydrolytic mechanisms that differ fundamentally from aerobic mammalian oxidation.
Benzene metabolic signatures in plasma, including altered amino acid and lipid metabolites, are associated with benzene-induced hematotoxicity in exposed workers.
Benzene exposure induces ferroptosis via GPX4 downregulation and disrupts hematopoietic homeostasis, providing mechanistic links to myelodysplasia.
Microbial metabolic pathways for benzene degradation in contaminated groundwater involve diverse taxa and enzymes that are targets for bioremediation research.

Description

Benzene metabolic process (GO:0018910) is the set of chemical reactions and pathways that transform benzene, a volatile and highly flammable aromatic hydrocarbon found in coal-derived naphtha. This process is central to toxicology, environmental microbiology, and occupational health because benzene is a ubiquitous environmental pollutant and a known human leukemogen. In mammals, benzene metabolism occurs primarily in the liver and involves cytochrome P450 enzymes that convert benzene into reactive intermediates capable of damaging hematopoietic stem cells. In contrast, anaerobic microorganisms can degrade benzene through entirely different biochemical routes, which are of interest for bioremediation of contaminated groundwater. Understanding benzene metabolic process is therefore essential for researchers studying chemical carcinogenesis, metabolic biomarkers, and microbial ecology. The pathway is also a paradigm for xenobiotic biotransformation, where the balance between detoxification and bioactivation determines toxicity. Recent studies have linked benzene metabolism to ferroptosis, mitochondrial dysfunction, and altered amino acid catabolism, expanding the mechanistic landscape beyond classical oxidation.

benzene metabolic process At A Glance

GO ID GO:0018910
GO term benzene metabolic process
Ontology biological_process
Synonym benzene metabolism
Major function Chemical transformation of benzene via oxidation, reduction, or hydrolysis, producing metabolites such as phenol, catechol, and hydroquinone in mammals, or ring-cleavage intermediates in microbes
Key mammalian enzymes Cytochrome P450 family members (e.g., CYP2E1), myeloperoxidase, and phase II conjugating enzymes
Key microbial taxa Anaerobic benzene-degrading consortia including Desulfobacteraceae and Peptococcaceae
Associated toxicity Bone marrow suppression, leukemia, and myelodysplasia
Research relevance Biomarker discovery, bioremediation, and mechanistic toxicology

What Is GO:0018910?

GO:0018910 benzene metabolic process is defined by QuickGO as the chemical reactions and pathways involving benzene, C6H6, a volatile, very inflammable liquid contained in the naphtha produced by the destructive distillation of coal, from which it is separated by fractional distillation. In practice, this term encompasses both mammalian enzymatic oxidation of benzene to phenolic and quinone metabolites and microbial degradation pathways that use benzene as a carbon source or electron donor under aerobic or anaerobic conditions.

Why Is benzene metabolic process Important in Cell Biology?

Benzene metabolic process is critically important because it determines whether benzene is detoxified or bioactivated into species that damage the hematopoietic system. The pathway is directly implicated in benzene-induced leukemia, aplastic anemia, and myelodysplastic syndromes, making it a focus for occupational health and risk assessment. In environmental science, microbial benzene metabolism underpins bioremediation strategies for contaminated groundwater and industrial sites. Additionally, plasma metabolomic signatures of benzene metabolism serve as candidate biomarkers for early detection of hematotoxicity in exposed populations.
Benzene metabolism generates reactive metabolites that are central to benzene-induced leukemia and bone marrow failure.
CYP2E1-mediated oxidation of benzene produces phenol, which can be further metabolized to catechol and hydroquinone, compounds with genotoxic potential.
Ferroptosis induction via GPX4 downregulation is a recently identified mechanism linking benzene metabolism to myelodysplasia.
Altered BCAA catabolism and mitochondrial ROS contribute to benzene-induced hematopoietic senescence.
Plasma metabolomics reveals critical metabolic signatures for benzene-induced hematotoxicity, supporting biomarker development.
Anaerobic benzene degradation pathways are essential for natural attenuation and bioremediation of contaminated sites.
Microbial diversity and metabolic pathways in petrochemical-polluted groundwater inform bioremediation strategies.
Chlorinated benzene degradation shares enzymatic principles with benzene metabolism, expanding the scope of environmental toxicology.
Understanding benzene metabolic process aids in designing safer industrial chemicals and exposure limits.
The pathway serves as a model for studying xenobiotic biotransformation and inter-individual susceptibility.

What Happens During benzene metabolic process?

Mammalian Phase I Oxidation by Cytochrome P450
In simple terms: In the liver, enzymes add oxygen to benzene to make it more reactive and water-soluble.
The initial step in mammalian benzene metabolism is oxidation by cytochrome P450 enzymes, predominantly CYP2E1, which converts benzene to benzene oxide, a reactive epoxide intermediate. Benzene oxide can spontaneously rearrange to phenol or be hydrolyzed to catechol and trans-1,2-dihydrodiol. This phase I metabolism is considered a bioactivation step because the resulting metabolites can form adducts with DNA and proteins. The balance between oxidation and detoxification influences individual susceptibility to benzene toxicity.
Phase II Conjugation and Detoxification
In simple terms: The body attaches molecules like sulfate or glucuronic acid to benzene metabolites to help excrete them.
Phenol, catechol, and hydroquinone produced in phase I are further metabolized by phase II enzymes, including sulfotransferases and glucuronosyltransferases, to form water-soluble conjugates that are excreted in urine. However, myeloperoxidase in bone marrow can convert hydroquinone to benzoquinone, a highly reactive species that contributes to hematotoxicity. Thus, phase II metabolism can be either detoxifying or activating depending on the tissue and enzyme context.
Microbial Aerobic and Anaerobic Benzene Degradation
In simple terms: Certain bacteria can break down benzene for food, using oxygen or other molecules in the process.
Microorganisms degrade benzene through aerobic pathways that typically begin with dioxygenase-mediated hydroxylation to form catechol, followed by ring cleavage. Under anaerobic conditions, benzene degradation proceeds via reductive mechanisms, often involving carboxylation or hydroxylation, and is carried out by specialized consortia such as sulfate-reducing bacteria. These microbial pathways are fundamentally different from mammalian metabolism and are critical for bioremediation of contaminated groundwater.
Reactive Metabolite Formation and Cellular Damage
In simple terms: Some benzene breakdown products are toxic and can damage cells, especially in the bone marrow.
Reactive metabolites such as benzoquinone and muconaldehyde can deplete glutathione, generate reactive oxygen species, and induce oxidative stress in hematopoietic cells. Recent evidence shows that benzene exposure downregulates GPX4 and induces ferroptosis, a form of iron-dependent cell death, in hematopoietic cells. Additionally, benzene-induced mitochondrial ROS disrupts BCAA catabolism, contributing to hematopoietic senescence. These mechanisms link benzene metabolism directly to bone marrow toxicity and leukemogenesis.
Metabolic Signatures and Biomarkers
In simple terms: Changes in blood metabolites can indicate how much benzene a person has been exposed to and how their body responds.
Plasma metabolomics studies in benzene-exposed workers have identified critical metabolic signatures, including alterations in amino acids, lipids, and energy metabolism, that correlate with hematotoxicity. These signatures reflect the systemic impact of benzene metabolism and offer potential biomarkers for early health surveillance. The integration of metabolomics with traditional exposure markers enhances our understanding of benzene metabolic process in human populations.

Key Genes Involved in GO:0018910 benzene metabolic process

The following genes and proteins are experimentally implicated in benzene metabolic process, including mammalian biotransformation enzymes and microbial degradation components.
GeneMajor RoleResearch Relevance
CYP2E1Primary cytochrome P450 enzyme oxidizing benzene to benzene oxide and phenolTarget for knockout and inhibition studies to assess benzene bioactivation
MPOMyeloperoxidase converts hydroquinone to benzoquinone in bone marrowKnockout models to study benzene-induced leukemogenesis
GPX4Glutathione peroxidase 4 protects against lipid peroxidation; downregulated by benzeneOverexpression and knockdown to study ferroptosis in hematotoxicity
GCLCGlutamate-cysteine ligase catalytic subunit, rate-limiting for glutathione synthesisModulation to assess glutathione depletion by benzene metabolites
NQO1NAD(P)H quinone dehydrogenase 1, detoxifies quinonesPolymorphism studies for susceptibility to benzene toxicity
EPHX1Microsomal epoxide hydrolase, metabolizes benzene oxideKnockout to determine role in benzene oxide detoxification
UGT1A6UDP-glucuronosyltransferase conjugates phenolOverexpression to enhance phenol excretion
SULT1A1Sulfotransferase conjugates phenolGenotyping for inter-individual variability in benzene metabolism
BCAT1Branched-chain amino acid transaminase 1, involved in BCAA catabolism disrupted by benzeneKnockout to study hematopoietic senescence
BCAT2Branched-chain amino acid transaminase 2, mitochondrial BCAA catabolismOverexpression to rescue benzene-induced metabolic defects
IRF4Interferon regulatory factor 4, implicated in benzene-induced hematopoietic senescenceKnockout and overexpression to study senescence pathways
TXNThioredoxin, antioxidant defense against benzene-induced oxidative stressOverexpression to test protection against ferroptosis
NFE2L2Nrf2, master regulator of antioxidant responseKnockout to assess sensitivity to benzene metabolites
HMOX1Heme oxygenase 1, antioxidant enzyme induced by oxidative stressReporter models to monitor benzene-induced stress
CYP2F1Cytochrome P450 family member with benzene-metabolizing activityComparative studies with CYP2E1
CYP2B6Cytochrome P450 enzyme contributing to benzene oxidationKnockout to evaluate redundancy in benzene metabolism
DesulfobacteraceaeAnaerobic benzene-degrading microbial familyMetagenomic and cultivation studies for bioremediation
PeptococcaceaeAnaerobic benzene-degrading microbial familyIsolation and genome sequencing for degradation pathways

How Is benzene metabolic process Regulated?

Benzene metabolic process is regulated at multiple levels. In mammals, CYP2E1 expression is induced by ethanol and other substrates, altering benzene bioactivation. Antioxidant response elements, such as Nrf2, regulate phase II enzymes and glutathione synthesis, modulating susceptibility to benzene metabolites. In bone marrow, myeloperoxidase activity and glutathione levels influence the balance between detoxification and reactive metabolite formation. Recent studies show that benzene exposure downregulates GPX4 and disrupts BCAA catabolism via mitochondrial ROS, indicating that metabolic and redox signaling pathways converge to regulate hematopoietic cell fate. In microbial systems, benzene degradation is regulated by substrate availability, electron acceptor availability, and community composition.

benzene metabolic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
CYP2E1Benzene-induced leukemia and hematotoxicityCyp2e1 knockout mice exposed to benzene
MPOBone marrow toxicity and leukemogenesisMpo knockout mice for benzene exposure studies
GPX4Ferroptosis-mediated myelodysplasiaGpx4 conditional knockout in hematopoietic cells
IRF4Hematopoietic senescenceIrf4 knockout and overexpression in hematopoietic stem cells
BCAT1/BCAT2BCAA catabolism disruption and senescenceBcat1/Bcat2 knockout cell models
Benzene-Induced Leukemia and Myelodysplasia
Chronic benzene exposure is associated with acute myeloid leukemia and myelodysplastic syndromes, and these outcomes are mechanistically linked to the reactive metabolites generated during benzene metabolism. Benzene oxide, phenol, hydroquinone, and benzoquinone can induce DNA damage, chromosomal aberrations, and epigenetic changes in hematopoietic stem and progenitor cells. Recent work demonstrates that benzene induces ferroptosis via GPX4 downregulation, contributing to myelodysplasia and hematotoxicity. These findings underscore the importance of benzene metabolic process in leukemogenesis and support the development of targeted interventions.
Hematotoxicity and Bone Marrow Failure
Benzene metabolism produces metabolites that accumulate in bone marrow, leading to aplastic anemia and pancytopenia. Myeloperoxidase-mediated oxidation of hydroquinone to benzoquinone is a key bioactivation step in hematopoietic tissue. Plasma metabolomics has revealed metabolic signatures associated with benzene-induced hematotoxicity, including altered amino acid and lipid profiles. Additionally, benzene disrupts BCAA catabolism through mitochondrial ROS, promoting hematopoietic senescence. These mechanisms highlight the systemic impact of benzene metabolism on bone marrow function.
Environmental Bioremediation and Microbial Degradation
Microbial benzene degradation is central to bioremediation of contaminated groundwater and industrial sites. Anaerobic benzene-degrading consortia, including sulfate-reducing bacteria, can mineralize benzene under anoxic conditions. Metagenomic studies in petrochemical-polluted groundwater have identified diverse microbial taxa and metabolic pathways linked to benzene degradation. Understanding these microbial processes informs strategies for natural attenuation and engineered bioremediation. Chlorinated benzene degradation shares some enzymatic principles, expanding the scope of environmental remediation research.

From benzene metabolic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does CYP2E1 mediate benzene bioactivation in vivo?Cyp2e1 knockout mouse
What is the role of GPX4 in benzene-induced ferroptosis?Gpx4 point-mutation or knockout cell lines
How does IRF4 regulate hematopoietic senescence?Irf4 overexpression and knockout hematopoietic cells
Can BCAA catabolism rescue benzene-induced senescence?BCAT1/BCAT2 knock-in or overexpression models
Which microbial genes are essential for anaerobic benzene degradation?Metagenomic library screening and gene knockout in model bacteria
What are the metabolic biomarkers of benzene exposure?Human plasma metabolomics with CRISPR-edited cell models for validation

How to Study the benzene metabolic process Process

MethodWhat It MeasuresTypical Application
LC-MS/MS metabolomicsQuantification of benzene metabolites and global metabolic profilesBiomarker discovery in exposed populations
CRISPR-Cas9 knockoutLoss-of-function of candidate genesTesting causality of CYP2E1, MPO, GPX4 in benzene toxicity
CRISPR point mutationSpecific amino acid changes to model polymorphismsStudying NQO1 or EPHX1 variants
RNA-seqTranscriptome-wide gene expression changesIdentifying pathways altered by benzene exposure
ProteomicsProtein abundance and post-translational modificationsValidating GPX4 downregulation and ferroptosis markers
MetagenomicsMicrobial community composition and functional genesBioremediation site assessment
Stable isotope tracingMetabolic flux through benzene degradation pathwaysElucidating mammalian and microbial metabolism
ImmunohistochemistryTissue localization of benzene-metabolizing enzymesBone marrow and liver studies
Metabolomics and Mass Spectrometry
Untargeted and targeted metabolomics using LC-MS or GC-MS are essential for profiling benzene metabolites and downstream metabolic changes. These methods can quantify phenol, catechol, hydroquinone, and conjugates in urine or plasma, as well as global metabolic signatures associated with hematotoxicity. Stable isotope-labeled benzene can be used to trace metabolic fluxes in vitro and in vivo.
CRISPR-Cas9 Gene Editing for Mechanistic Studies
CRISPR-Cas9 knockout, point mutation, and knock-in models enable precise interrogation of genes involved in benzene metabolism, such as CYP2E1, MPO, and GPX4. These models help determine whether candidate genes are causally involved in benzene-induced toxicity or merely correlated. Overexpression models can test protective roles of antioxidant enzymes like GPX4 and TXN.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal global changes in gene expression and protein abundance following benzene exposure, identifying pathways such as ferroptosis, BCAA catabolism, and oxidative stress response. These approaches are useful for discovering novel regulators of benzene metabolic process and for validating CRISPR screens.
Microbial Community Analysis and Metagenomics
16S rRNA sequencing, metagenomics, and metatranscriptomics are used to characterize microbial communities involved in benzene degradation in contaminated environments. These methods identify key taxa and metabolic genes, such as those in Desulfobacteraceae and Peptococcaceae, that drive anaerobic benzene metabolism.

How CRISPR Can Be Used to Study GO:0018910 benzene metabolic process

Knockout

CRISPR knockout of genes such as CYP2E1, MPO, and GPX4 allows researchers to determine their essential roles in benzene metabolic process and benzene-induced toxicity. For example, Cyp2e1 knockout mice show reduced benzene bioactivation and hematotoxicity, confirming its central role. GPX4 knockout cells are hypersensitive to benzene-induced ferroptosis, linking metabolism to cell death.

Point Mutation

Point mutations can model human polymorphisms in genes like NQO1 and EPHX1 that affect benzene metabolism and susceptibility. CRISPR-mediated knock-in of specific SNPs enables functional studies of how these variants alter enzyme activity and metabolite profiles. Such models are valuable for precision toxicology and risk assessment.

Knock-in

Knock-in of tagged or reporter alleles, such as GFP-tagged CYP2E1 or luciferase-tagged GPX4, allows real-time monitoring of protein expression and localization during benzene exposure. Knock-in of humanized alleles can create mouse models that better mimic human benzene metabolism for translational studies.

Overexpression

Overexpression of antioxidant enzymes like GPX4, TXN, or NFE2L2 can test whether enhancing detoxification protects against benzene-induced oxidative damage and ferroptosis. Overexpression of BCAT1 or BCAT2 may rescue BCAA catabolism defects and hematopoietic senescence caused by benzene. These models are useful for identifying therapeutic targets.

How EDITGENE Supports benzene metabolic process Research

Researchers studying benzene metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolite formation, cellular toxicity, or microbial degradation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes implicated in benzene metabolism.
Contact EDITGENE today to design your custom CRISPR model for benzene metabolic process research.

Frequently Asked Questions About benzene metabolic process

GO:0018910 is a Gene Ontology biological process term describing the chemical reactions and pathways involving benzene, a volatile aromatic hydrocarbon.
Key genes include CYP2E1, MPO, GPX4, NQO1, EPHX1, and BCAT1/2 in mammals, as well as microbial genes in Desulfobacteraceae and Peptococcaceae.
Benzene is metabolized to reactive metabolites like benzoquinone that damage DNA and induce oxidative stress in bone marrow, leading to leukemia.
CYP2E1 is the primary cytochrome P450 enzyme that oxidizes benzene to benzene oxide and phenol, a critical bioactivation step.
Yes, recent studies show benzene downregulates GPX4 and induces ferroptosis in hematopoietic cells, contributing to myelodysplasia.
Plasma metabolomics has identified altered amino acids, lipids, and energy metabolites as potential biomarkers of benzene-induced hematotoxicity.
Anaerobic bacteria can degrade benzene via reductive mechanisms, while aerobic bacteria use dioxygenases to form catechol and cleave the ring.
Knockout, point mutation, knock-in, and overexpression models of CYP2E1, GPX4, MPO, and BCAT1/2 are commonly used.
Yes, mammalian metabolism is oxidative and bioactivating, while microbial degradation often involves anaerobic reductive pathways for energy acquisition.
Benzene disrupts BCAA catabolism via mitochondrial ROS and IRF4 signaling, leading to hematopoietic senescence.

Conclusion

GO:0018910 benzene metabolic process encompasses a complex network of enzymatic reactions that determine the fate and toxicity of benzene in biological systems. From mammalian CYP450-mediated bioactivation to microbial anaerobic degradation, this process is central to toxicology, environmental science, and human health. Advances in CRISPR gene editing, metabolomics, and metagenomics continue to unravel the molecular players and regulatory mechanisms, offering new opportunities for disease prevention and bioremediation.

References

  1. 1. Bao R et al.. 2025. Benzene induces myelodysplasia and hematotoxicity via ferroptosis induction and downregulation of GPX4.. Arch Biochem Biophys 773:110606 PMID: 40914446
  2. 2. Guo X et al.. 2022. Plasma metabolomics study reveals the critical metabolic signatures for benzene-induced hematotoxicity.. JCI Insight 7(2) PMID: 35076025
  3. 3. Lovley DR. 2000. Anaerobic benzene degradation.. Biodegradation 11(2-3):107-16 PMID: 11440238
  4. 4. Liu Z et al.. 2025. Irf4 participates in benzene-induced hematopoietic senescence through mitochondrial ROS-dependent BCAA catabolism.. Toxicology 518:154271 PMID: 40885242
  5. 5. Snyder R et al.. 1996. An overview of benzene metabolism.. Environ Health Perspect 104 Suppl 6(Suppl 6):1165-71 PMID: 9118888
  6. 6. Zhang R et al.. 2024. Microbial diversity and metabolic pathways linked to benzene degradation in petrochemical-polluted groundwater.. Environ Int 188:108755 PMID: 38772206
  7. 7. Snyder R. 2002. Benzene and leukemia.. Crit Rev Toxicol 32(3):155-210 PMID: 12071572
  8. 8. Field JA et al.. 2008. Microbial degradation of chlorinated benzenes.. Biodegradation 19(4):463-80 PMID: 17917704
Contact Us
*
*
*
*
How did you hear about us: